In summary, our results reveal a previously unrecognized protective role of endothelial cell-specific BRG1 deletion in alleviating diabetic atherosclerosis and Ang II-induced AAA progression via inhibiting the inflammatory responses. The gene discussed is SMARCA4; the disease is atherosclerosis.